Five years on, biosimilars need support from all health care players
STAT
Today marks a milestone for the U.S. biosimilar market: the FDA approved our first biosimilar, Sandoz’s Zarxio, five years ago, on March 6, 2015.
Independence Day schedule
We will be closed on Friday, July 3 in observance of the Independence Day holiday. Delivery operations may vary across our network. We encourage you to review our full holiday schedule for more detailed information and to plan your orders accordingly.